Aer Therapeutics
San Diego, United States· Est. 2020
Mucus plugs block airways in up to half of moderate to severe COPD and asthma patients, reducing lung function, impairing quality of life, and increasing mortality. However, there are currently no effective mucolytic treatments for these patients. In the US alone, over 5 million people with COPD and 1.5 million with asthma are affected by mucus plugs.
Private Company
Total funding raised: $40M
About
Mucus plugs block airways in up to half of moderate to severe COPD and asthma patients, reducing lung function, impairing quality of life, and increasing mortality. However, there are currently no effective mucolytic treatments for these patients. In the US alone, over 5 million people with COPD and 1.5 million with asthma are affected by mucus plugs.
Small Molecules
Funding History
1Total raised:$40M
Series A$40MMay 15, 2022